Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches

Author
Date
2024-01Permanent link
https://hdl.handle.net/11351/10933DOI
10.1016/j.ad.2023.08.003
ISSN
0001-7310
PMID
37652096
Abstract
Atopic dermatitis is the most common chronic inflammatory skin disorder, affecting up to 20% of children and 10% of adults in developed countries. The pathophysiology of atopic dermatitis is complex and involves a strong genetic predisposition and T-cell driven inflammation. Although our understanding of the pathology and drivers of this disease has improved in recent years, there are still knowledge gaps in the immune pathways involved. Therefore, advances in new omics technologies in atopic dermatitis will play a key role in understanding the pathogenesis of this burden disease and could develop preventive strategies and personalized treatment strategies. In this review, we discuss the latest developments in genetics, transcriptomics, epigenomics, proteomics, and metagenomics and understand how integrating multiple omics datasets will identify potential biomarkers and uncover nets of associations between several molecular levels
Keywords
Omics; Atopic dermatitis; Next generation sequencingBibliographic citation
Carrascosa-Carrillo JM, Aterido A, Li T, Guillén Y, Martinez S, Marsal S, et al. Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches. Actas Dermosifiliogr. 2024 Jan;115(1):66–75.
Audience
Professionals
This item appears in following collections
- VHIR - Articles científics [1751]
The following license files are associated with this item:




